Monoclonal Antibodies (mAbs) Market Strategies and Forecasts, 2017 to 2026

1. Monoclonal Antibodies (mAbs) Market Market Size Worth $148.9 Billion by 2026 | CAGR: 6.1%

2. Monoclonal Antibodies (mAbs) Market Size Worth $148.9 Billion by 2026 “According to Polaris Market Research report, Monoclonal Antibodies (mAbs) is one of the rapidly evolving industry and the global Monoclonal Antibodies (mAbs) Market is estimated to reach $148.9 Billion by 2026 registering a healthy CAGR of 6.1% over the forecast period 2027 to 2026” The global Monoclonal Antibodies (mAbs) Market is driven by certain key factors such as technological innovation in the Monoclonal Antibodies (mAbs) industry, favorable regulatory scenario encouraging market players to develop new products, and efforts by manufacturers to boost the adoption of their offerings. Additionally, industry players are working on business expansion to target untapped markets and managing to deliver their products & services worldwide to augment their revenues. Monoclonal Antibodies (mAbs) Market Report Scope: The research report covers the segmentation of the Monoclonal Antibodies (mAbs) Market based on Product Type, Production System, Indication, Technology Platforms, Target Mechanism of Action, Route of Administration, Drug Types and region. Analysis of each of the segments projects the snapshot of the market over the forecast years includes the inclination of the market revenue, prevailing patterns, and emerging trends. Increasing consumer awareness regarding products coupled with a rise in disposable income is projected to propel the growth of the Monoclonal Antibodies (mAbs) Market over the forecast period. - 2 -

3. Monoclonal Antibodies (mAbs) Market Size Worth $148.9 Billion by 2026 By Product By By Indication By Technology By Target By Route By Drug By Region Type Production Platforms Mechanism of Types System of Action Administr ation •Fully Human •Murine •Chimeri c •Humani zed •Mammali an Cell Culture •Microbial Fermenta tion •Cancer •Inflammati on •Cardiovasc ular diseases •Transplant Rejection •Respiratory •Infectious diseases •Transgenic- Mouse •Antibody Drug Conjugate •Phage- Display •CGRP •HER2 •CTLA4 •TNF alpha •EGFR •VEGF •Anti CD •Anti-IL •IgGs, PD- 1/PD-L1 •Subcu taneo us •Intrav enous •Brande d Biologic s •Biosimil ars •North America (U.S., Canada) •Europe (France, Germany, UK, Italy, Spain, Netherlands , Austria) •Asia Pacific (Japan, China, India, Malaysia, Indonesia, South Korea) •Latin America (Brazil, Mexico, Argentina) •Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa) Browse Detailed Research Report On Monoclonal Antibodies (mAbs) Market Analysis: https://www.polarismarketresearch.com/industry-analysis/global-monoclonal-antibodies-mabs-market - 3 -

4. Monoclonal Antibodies (mAbs) Market Size Worth $148.9 Billion by 2026 Regional Outlook North America is anticipated to witness a significant growth rate with major revenue contribution in the Monoclonal Antibodies (mAbs) Market during the forecast period. Major factors influencing the regional market growth include improved infrastructural facilities, positive government initiatives, and the presence of established market players. The Monoclonal Antibodies (mAbs) Market in the Asia Pacific region is projected to grow at a substantial rate over the forecast period. The regional growth is attributed to increasing investments by leading companies to bring innovation in Monoclonal Antibodies (mAbs) industry and attract a large consumer base from leading economies such as India and China. Gain access to our latest research report that includes a detailed analysis of the COVID-19 pandemic influencing the Monoclonal Antibodies (mAbs) market and how market players devising effective strategies to mitigate the effect of the pandemic: https://www.polarismarketresearch.com/industry-analysis/global-monoclonal-antibodies-mabs- market/speak-to-analyst Competitive Landscape According to Polaris Market Research, the key players with a considerable market share in the Monoclonal Antibodies (mAbs) Market include (Pfizer, Inc., GlaxoSmithKline PLC, Novartis AG, Merck & Co., Inc., Eli Lily & Co., AstraZeneca, Amgen, Inc., Abbott Laboratories, Thermo Fisher Scientific, Inc., Bistro-Myers Squibb. Mylan N.V., Daiichi Sankyo Company, Ltd., Bayer AG, Hoffmann-La Roche Ltd., and Novo Nordisk A/S.). Companies are focusing on R&D activities and strategic collaborations to improve their product portfolio and increase consumer base. Adoption of the latest technologies and product advancement is the key strategy adopted by leading market players. Request for sample: https://www.polarismarketresearch.com/industry-analysis/global-monoclonal- antibodies-mabs-market/request-for-sample Table of Contents 1.Overview and Scope 1.1.Research goal & scope 1.2.Research assumptions 1.3.Research methodology 1.3.1.Primary data sources 1.3.2.Secondary data sources 1.4.Key take-away 1.5.Stakeholders - 4 -

5. Monoclonal Antibodies (mAbs) Market Size Worth $148.9 Billion by 2026 2.Executive Summary 2.1.Market definition 2.2.Market segmentation 3.Monoclonal Antibodies Market Insights 3.1.Monoclonal Antibodies – Industry snapshot 3.2.Monoclonal Antibodies - Ecosystem analysis 3.3.Monoclonal Antibodies Market Dynamics 3.3.1.Monoclonal Antibodies – Market Forces 3.3.1.1. Monoclonal Antibodies Market Driver Analysis 3.3.1.2. Monoclonal Antibodies Market Restraint/Challenges analysis 3.3.1.3. Monoclonal Antibodies Market Opportunity Analysis 3.3.2.Industry analysis - Porter's five forces 3.3.2.1. Bargaining power of supplier 3.3.2.2. Bargaining power of buyer 3.3.2.3. Threat of substitute 3.3.2.4. Threat of new entrant 3.3.2.5. Degree of competition 3.3.3.Monoclonal Antibodies Market PEST Analysis, 2017 3.3.4.Monoclonal Antibodies Market Value Chain Analysis 3.3.5.Monoclonal Antibodies Industry Trends 3.3.6.Competitive Ranking Analysis 4.Monoclonal Antibodies Testing Market Size and Forecast, 2017-2026 by Product Type 4.1.Key Findings 4.2.Fully Human 4.3.Murine 4.4.Chimeric 4.5.Humanized 5.Monoclonal Antibodies Testing Market Size and Forecast, 2017-2026 by Production System 5.1.Key Findings 5.2.Mammalian Cell Culture 5.3.Microbial Fermentation 6.Monoclonal Antibodies Testing Market Size and Forecast, 2017-2026 by Indication 6.1.Key Findings 6.2.Cancer 6.3.Inflammation 6.4.Cardiovascular diseases 6.5.Transplant Rejection 6.6.Respiratory 6.7.Infectious diseases 7.Monoclonal Antibodies Testing Market Size and Forecast, 2017-2026 by Technology Platforms 7.1.Key Findings 7.2.Transgenic-Mouse 7.3.Antibody Drug Conjugate 7.4.Phage-Display 8.Monoclonal Antibodies Testing Market Size and Forecast, 2017-2026 by Target Mechanism of Action 8.1.Key Findings 8.2.CGRP 8.3.HER2 8.4.CTLA4 8.5.TNF alpha 8.6.EGFR - 5 -

6. Monoclonal Antibodies (mAbs) Market Size Worth $148.9 Billion by 2026 8.7.VEGF 8.8.Anti CD 8.9.Anti-IL 8.10. 9.Monoclonal Antibodies Testing Market Size and Forecast, 2017-2026 by Care Delivery Setting 9.1.Key Findings 9.2.Primary 9.3.Specialty Care 10.Monoclonal Antibodies Testing Market Size and Forecast, 2017-2026 by Route of Administration 10.1. Key Findings 10.2. Subcutaneous 10.3. Intravenous 11.Monoclonal Antibodies Testing Market Size and Forecast, 2017-2026 by Drug Types 11.1. Key Findings 11.2. Branded Biologics 11.3. Biosimilars 12.Monoclonal Antibodies Testing Market Size and Forecast, 2017-2026 by Region 12.1. Key Findings 12.2. North America 12.2.1.U.S. 12.2.2.Canada 12.3. Europe 12.3.1.UK 12.3.2.Germany 12.3.3.Rest of Europe 12.4. Asia-Pacific 12.4.1.China 12.4.2.Japan 12.4.3.India 12.4.4.Rest of Asia-Pacific 12.5. Latin America 12.5.1.Brazil 12.5.2.Mexico 12.6. Middle East & Africa 12.6.1.South Africa 12.6.2.Rest of Middle East & Africa 13.Company Profiles 13.1. Pfizer, Inc., 13.1.1.Overview 13.1.2.Financials 13.1.3.Product Benchmarking 13.1.4.Recent Developments 13.2. GlaxoSmithKline PLC 13.2.1.Overview 13.2.2.Financials 13.2.3.Product Benchmarking 13.2.4.Recent Developments 13.3. Novartis AG 13.3.1.Overview 13.3.2.Financials 13.3.3.Product Benchmarking IgGs, PD-1/PD-L1 - 6 -

7. Monoclonal Antibodies (mAbs) Market Size Worth $148.9 Billion by 2026 13.3.4.Recent Developments 13.4. Merck & Co., Inc. 13.4.1.Overview 13.4.2.Financials 13.4.3.Product Benchmarking 13.4.4.Recent Developments 13.5. Eli Lily & Co. 13.5.1.Overview 13.5.2.Financials 13.5.3.Product Benchmarking 13.5.4.Recent Developments 13.6. AstraZeneca 13.6.1.Overview 13.6.2.Financials 13.6.3.Product Benchmarking 13.6.4.Recent Developments 13.7. Amgen, Inc. 13.7.1.Overview 13.7.2.Financials 13.7.3.Product Benchmarking 13.7.4.Recent Developments 13.8. Abbott Laboratories 13.8.1.Overview 13.8.2.Financials 13.8.3.Product Benchmarking 13.8.4.Recent Developments 13.9. Thermo Fisher Scientific, Inc. 13.9.1.Overview 13.9.2.Financials 13.9.3.Product Benchmarking 13.9.4.Recent Developments 13.10. Bistro-Myers Squibb. 13.10.1. Overview 13.10.2. Financials 13.10.3. Product Benchmarking 13.10.4. Recent Developments 13.11. Mylan N.V. 13.11.1. Overview 13.11.2. Financials 13.11.3. Product Benchmarking 13.11.4. Recent Developments 13.12. Daiichi Sankyo Company, Ltd. 13.12.1. Overview 13.12.2. Financials 13.12.3. Product Benchmarking 13.12.4. Recent Developments 13.13. Bayer AG 13.13.1. Overview 13.13.2. Financials 13.13.3. Product Benchmarking 13.13.4. Recent Developments - 7 -

8. Monoclonal Antibodies (mAbs) Market Size Worth $148.9 Billion by 2026 13.14. Hoffmann-La Roche Ltd. 13.14.1. Overview 13.14.2. Financials 13.14.3. Product Benchmarking 13.14.4. Recent Developments 13.15. Novo Nordisk A/S 13.15.1. Overview 13.15.2. Financials 13.15.3. Product Benchmarking 13.15.4. Recent Developments Access Press Release on Monoclonal Antibodies (mAbs) Market: https://www.polarismarketresearch.com/press-releases/global-monoclonal-antibodies-mabs-market About Polaris Market Research Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced and extremely qualified team of experts comprising SMEs, analysts and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers. E mail Id: sales@polarismarketresearch.com Web: www.polarismarketresearch.com Official Blog: http://polarismarketresearch.blogspot.com - 8 -